27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Amneal Pharmaceuticals (NYSE:AMRX) reported its Q3 earnings results on Friday, November 4, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Amneal Pharmaceuticals missed estimated earnings by 22.22%, reporting an EPS of $0.14 versus an estimate of $0.18.
Revenue was up $16.96 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 8.09% drop in the share price the next day.
Here's a look at Amneal Pharmaceuticals's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.20 | 0.13 | 0.20 | 0.20 |
| EPS Actual | 0.19 | 0.12 | 0.18 | 0.21 |
| Revenue Estimate | 536.34M | 503.97M | 537.35M | 545.06M |
| Revenue Actual | 559.36M | 497.63M | 536.90M | 528.59M |
To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!